ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Research vs. Delivery? Advisors Debate NCI Role In Review of Community Program.

November 21, 2008

NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection.

March 26, 2004

In Brief: Gritz Heads New Dept. At M.D. Anderson; NCI Grants Manager Leo Buscher honored

July 16, 1993

Nixon to Receive ACCC Annual Award

January 10, 1986

SEER Program Challenged, Will Face Review

May 9, 1980

Court Orders Selikoff to Release Data Tapes To Tobacco Companies

August 25, 1989